Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Inogen IncINGN · Entity 2083 | EVP, Engineering | September 28, 2021 | September 30, 2021 |
| Sight Sciences, Inc.SGHT · Entity 5537 | EVP, Operations & R&D | October 02, 2026 | October 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Inogen Inc
Report date September 28, 2021 · Filed September 30, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 69,735 |
Reported balance
After 2021-09-28 transaction · row 1
1 source rowRow 1 · 2021-09-28 · Exercise / conversion · Acquired 12,945 · Balance 69,735 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.81 · Expires 2022-03-27 | Direct | 0 |
Reported balance
After 2021-09-28 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-09-28 · Exercise / conversion · Disposed 12,945 · Balance 0 F1: Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is May 1, 2012. |
| Common StockSEC Table I · non-derivative | IndirectBy Spouse | 842 |
Reported balance
Holding disclosure · report date 2021-09-28 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 842 |
Filing footnotes · ownership attribution and instrument terms
F1: Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is May 1, 2012.
Sight Sciences, Inc.
Report date October 02, 2026 · Filed October 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 261,990 |
Reported balance
After 2026-10-02 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-10-02 · Sale · Disposed 2,988 · Balance 261,990 F1: Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs"). F2: Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $8.68 to $9.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3: Includes (i) 41,602 shares of Common Stock, and (ii) 220,388 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs").
F2: Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $8.68 to $9.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: Includes (i) 41,602 shares of Common Stock, and (ii) 220,388 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 02, 2026 Filed Oct 5, 2026 20:43 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | SaleCommon Stock | 2,988 | $8.85 | $26,452.76 |
DisclosureSEC source: 0001193125-26-414283 · ownership.xml · nonDerivative · entry 1 Taylor Brenton · CIK 0001596103 · EVP, Operations & R&D 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 261,990 F1 · shares: Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs"). F2 · price: Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $8.68 to $9.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes (i) 41,602 shares of Common Stock, and (ii) 220,388 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 23:33 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | SaleCommon Stock | 2,829 | $5.42 | $15,333.18 |
DisclosureSEC source: 0001193125-26-296593 · ownership.xml · nonDerivative · entry 1 Taylor Brenton · CIK 0001596103 · EVP, Operations & R&D 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 264,978 F1 · shares: Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs"). F2 · price: Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $5.24 to $5.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes (i) 36,696 shares of Common Stock, and (ii) 228,282 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 20:27 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | SaleCommon Stock | 2,869 | $3.70 | $10,615.30 |
DisclosureSEC source: 0001193125-26-142227 · ownership.xml · nonDerivative · entry 1 Taylor Brenton · CIK 0001596103 · EVP, Operations & R&D 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 267,807 F1 · shares: Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs"). F2 · price: Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $3.63 to $3.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes (i) 31,631 shares of Common Stock, and (ii) 236,176 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested. Read SEC document |
| February 03, 2026 Filed Feb 5, 2026 21:47 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | GrantCommon Stock | 100,464 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-039549 · ownership.xml · nonDerivative · entry 1 Taylor Brenton · CIK 0001596103 · EVP, Operations & R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 270,676 F1 · shares: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's 2021 Incentive Award Plan. The RSUs vest in 16 equal quarterly installments commencing March 31, 2026 and continuing through December 31, 2029, subject to the Reporting Person's continued service to the Issuer through each vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to $650,000 divided by the closing price of the Common Stock on the grant date, which was February 3, 2026. F2 · balance_after: Includes (i) 26,606 shares of Common Stock, and (ii) 244,070 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested. Read SEC document |
| January 06, 2026 Filed Jan 7, 2026 00:01 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | SaleCommon Stock | 619 | $7.48 | $4,630.12 |
DisclosureSEC source: 0001193125-26-004972 · ownership.xml · nonDerivative · entry 1 Taylor Brenton · CIK 0001596103 · EVP, Operations & R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 170,212 F1 · shares: Reflects shares of the Issuer's common stock, par value $0.001 per share, sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units. F2 · price: Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $7.39 to $7.67, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 17, 2025 Filed Nov 18, 2025 22:24 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | SaleCommon Stock | 14,418 | $7.06 | $101,791.08 |
DisclosureSEC source: 0001193125-25-286462 · ownership.xml · nonDerivative · entry 1 Taylor Brenton · CIK 0001596103 · EVP, Operations & R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 170,831 F1 · shares: Reflects shares of the Issuer's common stock, par value $0.001 per share, sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units. F2 · price: Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $6.92 to $7.19, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 06, 2025 Filed Oct 9, 2025 00:12 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | SaleCommon Stock | 591 | $3.37 | $1,991.67 |
DisclosureSEC source: 0001193125-25-234847 · ownership.xml · nonDerivative · entry 1 Taylor Brenton · CIK 0001596103 · EVP, Operations & R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,249 F1 · shares: Reflects shares of the Issuer's common stock, par value $0.001 per share, sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units. F2 · price: Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $3.32 to $3.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 02, 2025 Filed Sep 3, 2025 20:23 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | GrantCommon Stock | 25,840 | $0.00 | $0.00 |
DisclosureSEC source: 0001596103-25-000006 · ownership.xml · nonDerivative · entry 1 Taylor Brenton · CIK 0001596103 · EVP, Operations & R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,840 F1 · shares: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's 2021 Incentive Award Plan. The RSUs vest in 16 equal quarterly installments commencing September 30, 2025 and continuing through June 30, 2029, subject to the Reporting Person's continued service to the Issuer through each vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to approximately $100,000 of shares of Common Stock as determined by the closing price on the grant date, September 2, 2025. The RSUs have no expiration date. Read SEC document |
| November 12, 2024 Filed Nov 19, 2024 02:53 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | GrantCommon Stock | 160,000 | $4.59 | $734,400.00 |
DisclosureSEC source: 0000950170-24-128222 · ownership.xml · nonDerivative · entry 1 Taylor Brenton · CIK 0001596103 · EVP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,000 F1 · shares: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's 2021 Incentive Award Plan. The RSUs vest in four equal annual installments commencing November 15, 2025 and continuing through November 15, 2028, subject to the Reporting Person's continued service to the Issuer through each vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share. The RSUs have no expiration date. Read SEC document |
| September 28, 2021 Filed Sep 30, 2021 23:54 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (Right to Buy) · Derivative | 12,945 | $0.00 Strike: $0.81 | $0.00 |
DisclosureSEC source: 0001209191-21-058304 · doc4.xml · derivative · entry 3 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,945 shares Expires 2022-03-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is May 1, 2012. Read SEC document |
| September 28, 2021 Filed Sep 30, 2021 23:54 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 12,945 | $0.81 | $10,485.45 |
DisclosureSEC source: 0001209191-21-058304 · doc4.xml · nonDerivative · entry 1 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,735 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 20:33 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionRestricted Stock Unit · Derivative | 273 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-054772 · doc4.xml · derivative · entry 4 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,730 Underlying: Common Stock · 273 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F3 · derivative.exercise_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on March 1, 2021, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month. F3 · derivative.expiration_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on March 1, 2021, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 20:33 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 345 | $60.57 | $20,896.65 |
DisclosureSEC source: 0001209191-21-054772 · doc4.xml · nonDerivative · entry 2 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,790 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on September 1, 2021. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 20:33 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 273 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-054772 · doc4.xml · nonDerivative · entry 1 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,135 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2021 Filed Jul 29, 2021 20:16 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,942 | $0.00 Strike: $38.54 | $0.00 |
DisclosureSEC source: 0001209191-21-048497 · doc4.xml · derivative · entry 4 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,303 Underlying: Common Stock · 7,942 shares Expires 2022-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month on the same day as the vesting commencement date. The vesting commencement date for this option is May 1, 2015. Read SEC document |
| July 27, 2021 Filed Jul 29, 2021 20:16 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 7,942 | $75.02 | $595,808.05 |
DisclosureSEC source: 0001209191-21-048497 · doc4.xml · nonDerivative · entry 2 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,862 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 24, 2020. F2 · price: Represents the weighted average share price of an aggregate total of 7,942 shares sold in the price range of $75.00 to $75.24 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 27, 2021 Filed Jul 29, 2021 20:16 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 7,942 | $38.54 | $306,084.68 |
DisclosureSEC source: 0001209191-21-048497 · doc4.xml · nonDerivative · entry 1 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,804 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 21:59 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionRestricted Stock Unit · Derivative | 273 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-037855 · doc4.xml · derivative · entry 4 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,003 Underlying: Common Stock · 273 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F3 · derivative.exercise_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on March 1, 2021, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month. F3 · derivative.expiration_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on March 1, 2021, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 21:59 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 344 | $60.34 | $20,756.96 |
DisclosureSEC source: 0001209191-21-037855 · doc4.xml · nonDerivative · entry 2 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,862 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on June 1, 2021. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 21:59 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 273 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-037855 · doc4.xml · nonDerivative · entry 1 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,206 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 15, 2021 Filed Apr 19, 2021 23:26 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (Right to Buy · Derivative | 2,841 | $0.00 Strike: $38.54 | $0.00 |
DisclosureSEC source: 0001209191-21-027401 · doc4.xml · derivative · entry 4 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,245 Underlying: Common Stock · 2,841 shares Expires 2022-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month on the same day as the vesting commencement date. The vesting commencement date for this option is May 1, 2015. Read SEC document |
| April 15, 2021 Filed Apr 19, 2021 23:26 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 2,841 | $65.21 | $185,251.67 |
DisclosureSEC source: 0001209191-21-027401 · doc4.xml · nonDerivative · entry 2 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,933 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 24, 2020 F2 · price: Represents the weighted average share price of an aggregate total of 2,841 shares sold in the price range of $65.00 to $65.55 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| April 15, 2021 Filed Apr 19, 2021 23:26 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 2,841 | $38.54 | $109,492.14 |
DisclosureSEC source: 0001209191-21-027401 · doc4.xml · nonDerivative · entry 1 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,774 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 14, 2021 Filed Apr 16, 2021 00:16 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (Right to Buy · Derivative | 6,104 | $0.00 Strike: $38.54 | $0.00 |
DisclosureSEC source: 0001209191-21-026888 · doc4.xml · derivative · entry 7 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,086 Underlying: Common Stock · 6,104 shares Expires 2022-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month on the same day as the vesting commencement date. The vesting commencement date for this option is May 1, 2015. Read SEC document |
| April 14, 2021 Filed Apr 16, 2021 00:16 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 6,104 | $60.22 | $367,587.15 |
DisclosureSEC source: 0001209191-21-026888 · doc4.xml · nonDerivative · entry 4 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,933 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 24, 2020 F2 · price: Represents the weighted average share price of an aggregate total of 6,104 shares sold in the price range of $60.00 to $60.55 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| April 14, 2021 Filed Apr 16, 2021 00:16 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 6,104 | $38.54 | $235,248.16 |
DisclosureSEC source: 0001209191-21-026888 · doc4.xml · nonDerivative · entry 3 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,037 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 13, 2021 Filed Apr 16, 2021 00:16 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (Right to Buy · Derivative | 1,838 | $0.00 Strike: $38.54 | $0.00 |
DisclosureSEC source: 0001209191-21-026888 · doc4.xml · derivative · entry 6 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,190 Underlying: Common Stock · 1,838 shares Expires 2022-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month on the same day as the vesting commencement date. The vesting commencement date for this option is May 1, 2015. Read SEC document |
| April 13, 2021 Filed Apr 16, 2021 00:16 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 1,838 | $60.00 | $110,280.00 |
DisclosureSEC source: 0001209191-21-026888 · doc4.xml · nonDerivative · entry 2 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,933 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 24, 2020 Read SEC document |
| April 13, 2021 Filed Apr 16, 2021 00:16 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 1,838 | $38.54 | $70,836.52 |
DisclosureSEC source: 0001209191-21-026888 · doc4.xml · nonDerivative · entry 1 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,771 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 17, 2021 Filed Mar 19, 2021 21:49 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (Right to Buy · Derivative | 14,765 | $0.00 Strike: $16.62 | $0.00 |
DisclosureSEC source: 0001209191-21-022151 · doc4.xml · derivative · entry 5 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,765 shares Expires 2021-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Subject to the reporting person's continuing service, 1/48th of the total shares subject to the option shall vest every month after March 1, 2014. F5 · derivative.expiration_date: Previously filed form 4s incorrectly listed the expiration date as 04/01/2024. Read SEC document |
| March 17, 2021 Filed Mar 19, 2021 21:49 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 8,565 | $51.94 | $444,846.40 |
DisclosureSEC source: 0001209191-21-022151 · doc4.xml · nonDerivative · entry 3 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,933 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 24, 2020 F3 · price: Represents the weighted average share price of an aggregate total of 8,565 shares sold in the price range of $51.62 to $52.24 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 17, 2021 Filed Mar 19, 2021 21:49 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 6,200 | $51.21 | $317,508.82 |
DisclosureSEC source: 0001209191-21-022151 · doc4.xml · nonDerivative · entry 2 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,498 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 24, 2020 F2 · price: Represents the weighted average share price of an aggregate total of 6,200 shares sold in the price range of $50.60 to $51.59 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 17, 2021 Filed Mar 19, 2021 21:49 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 14,765 | $16.62 | $245,394.30 |
DisclosureSEC source: 0001209191-21-022151 · doc4.xml · nonDerivative · entry 1 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,698 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2021 Filed Mar 4, 2021 22:55 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (Right to Buy · Derivative | 14,765 | $0.00 Strike: $16.62 | $0.00 |
DisclosureSEC source: 0001209191-21-017957 · doc4.xml · derivative · entry 6 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,765 Underlying: Common Stock · 14,765 shares Expires 2024-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Subject to the reporting person's continuing service, 1/48th of the total shares subject to the option shall vest every month after March 1, 2014. Read SEC document |
| March 03, 2021 Filed Mar 4, 2021 22:55 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 643 | $49.41 | $31,769.73 |
DisclosureSEC source: 0001209191-21-017957 · doc4.xml · nonDerivative · entry 4 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,933 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 24, 2020 F4 · price: Represents the weighted average share price of an aggregate total of 643 shares sold in the price range of $49.24 to $50.205 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 03, 2021 Filed Mar 4, 2021 22:55 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 2,560 | $48.55 | $124,295.68 |
DisclosureSEC source: 0001209191-21-017957 · doc4.xml · nonDerivative · entry 3 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,576 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 24, 2020 F3 · price: Represents the weighted average share price of an aggregate total of 2,560 shares sold in the price range of $48.22 to $49.10 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 03, 2021 Filed Mar 4, 2021 22:55 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 11,562 | $47.85 | $553,218.58 |
DisclosureSEC source: 0001209191-21-017957 · doc4.xml · nonDerivative · entry 2 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,136 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 24, 2020 F2 · price: Represents the weighted average share price of an aggregate total of 11,562 shares sold in the price range of $47.20 to $48.20 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 03, 2021 Filed Mar 4, 2021 22:55 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 14,765 | $16.62 | $245,394.30 |
DisclosureSEC source: 0001209191-21-017957 · doc4.xml · nonDerivative · entry 1 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,698 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 23:00 UTC | Inogen Inc INGN · Entity 2083 | GrantRestricted Stock Unit · Derivative | 3,763 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-017169 · doc4.xml · derivative · entry 5 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,763 Underlying: Common Stock · 3,763 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F4 · derivative.exercise_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on March 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month. F4 · derivative.expiration_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on March 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 23:00 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionRestricted Stock Unit · Derivative | 1,092 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-017169 · doc4.xml · derivative · entry 4 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,276 Underlying: Common Stock · 1,092 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F1 · derivative.exercise_date: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on March 1, 2021. F3 · derivative.expiration_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on March 1, 2021, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 23:00 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 751 | $53.14 | $39,908.14 |
DisclosureSEC source: 0001209191-21-017169 · doc4.xml · nonDerivative · entry 2 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,933 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on March 1, 2021. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 23:00 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 1,092 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-017169 · doc4.xml · nonDerivative · entry 1 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,684 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 21:09 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (Right to Buy · Derivative | 14,764 | $0.00 Strike: $16.62 | $0.00 |
DisclosureSEC source: 0001209191-21-007205 · doc4.xml · derivative · entry 5 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,530 Underlying: Common Stock · 14,764 shares Expires 2024-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Subject to the reporting person's continuing service, 1/48th of the total shares subject to the option shall vest every month after March 1, 2014. F5 · balance_after: Form 4 filed on 01/11/2021 incorrectly reported the number of derivative securities beneficially owned. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 21:09 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 1,398 | $50.11 | $70,060.07 |
DisclosureSEC source: 0001209191-21-007205 · doc4.xml · nonDerivative · entry 3 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,592 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 24, 2020 F3 · price: Represents the weighted average share price of an aggregate total of 1,398 shares sold in the price range of $50.04 to $50.25 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 21:09 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 13,366 | $49.66 | $663,722.15 |
DisclosureSEC source: 0001209191-21-007205 · doc4.xml · nonDerivative · entry 2 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,990 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 24, 2020 F2 · price: Represents the weighted average share price of an aggregate total of 13,366 shares sold in the price range of $49.03 to $50.03 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 21:09 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 14,764 | $16.62 | $245,377.68 |
DisclosureSEC source: 0001209191-21-007205 · doc4.xml · nonDerivative · entry 1 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,356 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 26, 2021 Filed Jan 28, 2021 21:36 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (Right to Buy · Derivative | 7,942 | $0.00 Strike: $38.54 | $0.00 |
DisclosureSEC source: 0001209191-21-005891 · doc4.xml · derivative · entry 4 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,028 Underlying: Common Stock · 7,942 shares Expires 2022-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month on the same day as the vesting commencement date. The vesting commencement date for this option is May 1, 2015. Read SEC document |
| January 26, 2021 Filed Jan 28, 2021 21:36 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 7,942 | $50.02 | $397,274.72 |
DisclosureSEC source: 0001209191-21-005891 · doc4.xml · nonDerivative · entry 2 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,592 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 24, 2020 F2 · price: Represents the weighted average share price of an aggregate total of 7,942 shares sold in the price range of $50.00 to $50.18 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 26, 2021 Filed Jan 28, 2021 21:36 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 7,942 | $38.54 | $306,084.68 |
DisclosureSEC source: 0001209191-21-005891 · doc4.xml · nonDerivative · entry 1 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,534 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 08, 2021 Filed Jan 12, 2021 01:16 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (Right to Buy · Derivative | 11,017 | $0.00 Strike: $16.62 | $0.00 |
DisclosureSEC source: 0001209191-21-003144 · doc4.xml · derivative · entry 6 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,294 Underlying: Common Stock · 11,017 shares Expires 2024-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Subject to the reporting person's continuing service, 1/48th of the total shares subject to the option shall vest every month after March 1, 2014. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.